在冠状动脉疾病和心力衰竭中进行心血管改造
Gerd Heusch1, Peter Libby2, Bernard Gersh3
1Institut für Pathophysiologie, Universitätsklinikum Essen, Essen, Germany.
Lancet (London, England)
|May 17, 2014
概括
心脏和血管重塑,最初是适应性的,可以变得致病性. 本综述探讨了动脉样硬化,缺血-再注射损伤和心力衰竭的重塑,强调了治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 病理生理学 病理生理学
背景情况:
- 心脏和血管重塑是对各种刺激的复杂反应.
- 最初适应性,持续的重塑可以导致致病性结构变化.
- 重塑会影响多种细胞类型,包括心肌细胞,内皮,光滑肌细胞和间歇细胞,以及细胞外基质.
研究的目的:
- 在关键心血管疾病中描述重塑过程.
- 确定潜在的创新治疗策略,用于心血管改造.
主要方法:
- 本综述综合了有关心血管改造的现有文献.
- 它专注于与动脉样硬化,缺血-再输伤害和心力衰竭相关的重塑.
主要成果:
- 持续的病理改造涉及自我延续的结构变化.
- 该综述详细介绍了各种心血管疾病中的细胞和矩阵反应.
结论:
- 了解重塑机制对于开发有效治疗方法至关重要.
- 调节和代谢策略显示出治疗干预心血管改造的前景.
相关概念视频
Heart Failure II: Pathophysiology
1.8K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.8K
Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.8K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.8K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K


